Skip to main content
. 2018 Sep 14;9(5):2143–2153. doi: 10.1007/s13300-018-0501-6

Table 2.

Baseline characteristics of patients enrolled in the COACH support program and matched control patients

COACH (n = 1724) Control (n = 1724)
Gender,a n (%)
 Female 824 (48) 824 (48)
 Male 900 (52) 900 (52)
Age group,a n (%)
 18–47 years 378 (22) 378 (22)
 48–55 years 404 (23) 404 (23)
 56–61 years 460 (27) 460 (27)
 ≥ 62 years 482 (28) 482 (28)
Pre-study insulin use,a n (%)
 Insulin glargine 100 U/mL 783 (45) 783 (45)
 Other insulin 923 (54) 923 (54)
 Insulin naive 18 (1) 18 (1)
Diabetes, n (%)
 Type 1 115 (6.7) 127 (7.4)
 Type 2 814 (47) 869 (50)
 Unknown 795 (46) 728 (42)
Health insurance plan, n (%)
 Assistanceb 1,007 (58)** 741 (43)
 Commercial 579 (34)** 720 (42)
 Medicare 87 (5)** 204 (12)
 Cash 32 (2)** 20 (1)
 Managed Medicaid 13 (1)** 26 (2)
 Medicaid 6 (0.4)** 13 (1)
Copay for first prescription of insulin glargine,a,c n (%)
 US $0 141 (8.0) 141 (8.0)
 US $0.01–14.99 109 (6.0) 109 (6.0)
 US $15 1,222 (71) 1,222 (71)
 > US $15 251 (15) 251 (15)
Practitioner specialty, n (%)
 Endocrinology 567 (33) 555 (32)
 Family medicine 445 (26) 443 (26)
 Internal medicine 296 (17) 345 (20)
 Family practice 217 (13) 174 (10)
 Nurse practitioner 38 (2) 24 (1)
 Emergency medicine 19 (1) 16 (1)
 Physician assistant 16 (1) 24 (1)
 Diabetes 15 (1) 26 (2)
 Internal medicine/pediatrics 15 (1) 12 (1)
 General practice 12 (1) 23 (1)
 Unknown 13 (1) 10 (1)
 Other 0 (0)* 68 (4)

Percentages may not add up to 100% due to rounding

*P < 0.05 vs control patients and **P < 0.0001 vs control patients for chi-square test

aCharacteristic used for matching patients in the COACH cohort with control patients

bIncludes coupons, discount cards, and privately or state-funded assistance programs for uninsured, low-income patients or those who are ineligible for public programs

cCopay data were missing for 1 patient in the COACH cohort, who was matched to a patient in the control cohort with missing copay data